Someone answer me this, Why has no one questioned that we haven't gotten the go ahead on cd16/17. Fda is just continuing eind which is great for patients but not for the company...in fact it can be argued it hurts the company from an immediate supply POV. Everyone talks as if CD16/17 is a done deal...It was filed 2 months ago and FDA has yet to comment and we haven't even begun to enroll and as per NP FDA are the ones who asked for it! Yet no one seems to be concerned about this. The FDA has clamped all of our tires but is still letting us rev the engine.